Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

  • There is currently no data for MIX

Interim Management Statement

10 Nov 2023 13:30

RNS Number : 1304T
Mobeus Income & Growth VCT PLC
10 November 2023
 

MOBEUS INCOME & GROWTH VCT PLC

("the Company")

LEI: 213800HKOSEVWS7YPH79

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2023

 

Mobeus Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 September 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 30 September 2023

(unaudited)

At 30 June 2023

(unaudited)

Net assets attributable to shareholders

£102.94 million

£100.15 million

Shares in issue

165,644,278

156,718,602

Net asset value (NAV) per share

62.15 pence

60.12 pence

Cumulative dividends paid

161.80 pence

161.80 pence

Cumulative Total return (net asset value basis) per share since inception

223.95 pence

221.92 pence

 

The NAV per share has increased by 2.03 pence in the quarter (an increase of 3.4% from the NAV per share at 30 June 2023).

 

INVESTMENT ACTIVITY DURING THE PERIOD

New Investment during the period

On 26 July 2023, the Company completed a new investment of £0.49 million into Mable Therapy Limited, a digital health platform for speech therapy and counselling for children and young adults.

 

On 3 August 2023, the Company completed a new investment of £0.48 million into Branchspace Limited, a digital retailing consultancy and software provider to the aviation and travel industry.

 

Further Investments during the period

On 4 July 2023, a follow on equity investment of £0.41 million was made into Legatics Holdings Limited, a SaaS LegalTech software provider.

 

On 11 August 2023, a follow on loan investment of £0.15 million was made into Orri Limited, an intensive day care provider for adults with eating disorders.

 

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

There has been no activity post-quarter.

 

SHARE BUYBACK DURING THE PERIOD

On 26 September 2023, the Company purchased 946,163 of its own ordinary shares at a price of 57.11 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

DIVIDEND DECLARED DURING THE PERIOD

On 21 September 2023, a second interim dividend of 4.50 pence per share in respect of the year ending 31 December 2023 was declared and was paid on 8 November 2023 to all Shareholders whose names were on the register on 29 September 2023. Payment of this interim dividend will reduce NAV per share (shown above) to 57.65 pence and increase cumulative dividends paid to 166.30 pence per share.

 

Please note that all of the above information is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFMFDSEDSEFF
Date   Source Headline
2nd Jul 20199:14 amRNSRealisation of investments
15th May 20199:53 amRNSTransaction in Own Shares
13th May 20199:01 amRNSTransaction in Own Shares
8th May 20193:26 pmRNS1st Quarter Results - Interim Management Statement
8th May 20193:22 pmRNSResult of AGM
23rd Apr 201910:05 amRNSTransaction in Own Shares - Amended
4th Apr 20199:21 amRNSTransaction in Own Shares
3rd Apr 20199:13 amRNSAnnual Financial Report
27th Mar 20195:52 pmRNSAnnual Results for the year ended 31 December 2018
28th Jan 20193:10 pmRNSIssue of Equity
20th Dec 20189:26 amRNSTransaction in Own Shares
15th Nov 20189:45 amRNSTransaction in Own Shares
6th Nov 20183:42 pmRNSInterim Management Statement 3rd Quarter Results
27th Sep 201811:18 amRNSTransaction in Own Shares
20th Aug 201810:15 amRNSTransaction in Own Shares
20th Aug 201810:10 amRNSNational Storage Mechanism - Half Year Report
14th Aug 20189:41 amRNSHalf-year Report
2nd Jul 20184:19 pmRNSTotal Voting Rights
28th Jun 20184:56 pmRNSTransaction in Own Shares
9th May 20184:52 pmRNSInterim Management Statement 31 March 2018
9th May 20184:47 pmRNSResult of AGM
9th Apr 201810:33 amRNSTransaction in Own Shares
27th Mar 20185:22 pmRNSAnnual Financial Report
27th Mar 20184:13 pmRNSAnnual Financial Report
13th Mar 20184:25 pmRNSIssue of Equity
25th Jan 20189:18 amRNSIssue of Equity
5th Jan 201812:37 pmRNSRealisation of investment in Gro-Group
5th Jan 201811:21 amRNSTotal Voting Rights
20th Dec 20175:48 pmRNSTransaction in Own Shares
20th Dec 20171:52 pmRNSPublication of Suppl.Prospcts
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:14 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:11 amRNSJoint Announcement - Fundraising Update
22nd Nov 20179:28 amRNSIssue of Equity
21st Nov 20179:59 amRNSIssue of Equity
16th Nov 20179:26 amRNSTransaction in Own Shares
10th Nov 201710:22 amRNSIssue of Equity
8th Nov 20174:30 pmRNSInterim Management Statement 30 September 2017
1st Nov 201712:40 pmRNSIncrease in Offer size. Expiry of early incentive.
23rd Oct 201711:33 amRNSOver-allotment facility
20th Oct 20172:19 pmRNSDirector/PDMR Shareholding
20th Oct 20172:17 pmRNSDirector/PDMR Shareholding
20th Oct 20172:14 pmRNSIssue of Equity
2nd Oct 201712:19 pmRNSIssue of Equity Replacement
29th Sep 201710:16 amRNSDirector/PDMR Shareholding - Replacement
29th Sep 20179:06 amRNSDirector/PDMR Shareholding
29th Sep 20179:02 amRNSIssue of Equity
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.